Trials / Unknown
UnknownNCT00431145
Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
Influence of Combined Therapy of Niacin and Statins on Stem Cell Mobilization and Inflammatory Parameters in Patients Suffering From Coronary Artery Disease - Randomized Clinical Study -
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (planned)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to show additional effects of the combined therapy of niacin and statins analyzing number and function of EPCs and other stem cell populations and adiponectin as well as hsCRP levels in patients with CAD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Niacin | |
| DRUG | Niacin+Statin |
Timeline
- Start date
- 2006-10-01
- First posted
- 2007-02-05
- Last updated
- 2007-02-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00431145. Inclusion in this directory is not an endorsement.